Our Work
Influenza and the Antiviral, Baloxavir


Why the Flu Hits Like a Ton of Bricks
The illustration follows the pathway and mechanism of the influenza virus, its spread throughout the body, and resultant symptoms.


Why the Flu Hits Like a Ton of Bricks
The illustration follows the pathway and mechanism of the influenza virus, its spread throughout the body, and resultant symptoms.


The “Bug” Stops Here
The new antiviral Baloxavir kills the influenza virus in one day, with just one dose, because it stops viral replication before it starts. The illustration follows the pathway of influenza infection of a cell and mechanism of action for Baloxavir, a cap-dependent endonuclease inhibitor.


The “Bug” Stops Here
The new antiviral Baloxavir kills the influenza virus in one day, with just one dose, because it stops viral replication before it starts. The illustration follows the pathway of influenza infection of a cell and mechanism of action for Baloxavir, a cap-dependent endonuclease inhibitor.
Client
- BioScience Communications / Genentech
Category
- Medical Illustration
- Information Graphics
Industry
- Pharma / Biotechnology
- Healthcare
Audience
- Professional Education
Specialty
- Infectious Diseases
- Cell / Molecular Biology
- Immunology
- Biotechnology